One Sam's Club Recall Pulled Almost 150,000 Boxes Of Treats Off The Shelves
In December 2022, the Canada-based company Sublime Desserts issued a recall for 148,000 units of its Member's Mark Holiday Macarons (sold exclusively at Sam's Club) because of potential contamination from plastic particles. Because the macarons were frozen, there was concern that consumers might keep them long after the initial purchase (the products did not expire until October to December 2023, according to the dates on the packaging). The Food and Drug Administration (FDA) labeled the action as a Class II recall, indicating that the contaminant might cause temporary or reversible health problems, but was unlikely to create serious or lasting health issues. No health problems related to the macarons were reported at the time of the recall.
Read more: Discontinued Costco Grocery Products We Probably Won't Get Back
Recalls are part of the business of running retail giants in the U.S. and abroad, and Sam's Club has not been immune to them. Over the past decade, Sam's Club food recalls have affected millions, for a variety of reasons. Salmonella was the culprit behind a recall of Jennie-O All Natural Turkey Burgers in 2011 and JIF peanut butter in 2022. The equally gruesome bacteria, listeria, led to the removal of various stone fruits in 2024 as well as 26 different kinds of muffins in 2021. Meanwhile, lack of accurate information caused a 2024 recall of Member's Mark Breaded Mozzarella Sticks. Rich Products, the producer of the breaded cheese sticks, failed to list soy and egg among the ingredients, both of which can cause serious health problems for those allergic to them.
Curiously, particles of plastic are at the heart of several Sam's Club recalls. What's meant by "plastic particles" is not the microplastics that are an unavoidable part of eating and drinking today, but larger pieces, such as those found in cans of Member's Mark Premium Natural Chunk Chicken Breast in Water in 2018 and frozen chicken nugget products from Tyson in 2014.
This list of recalls is in no way a criticism of Sam's Club. If anything, it underscores the retailer's commitment to keeping its customers safe and abiding by federal requirements to remove potentially hazardous food items.
For more food and drink goodness, join The Takeout's newsletter. Get taste tests, food & drink news, deals from your favorite chains, recipes, cooking tips, and more!
Read the original article on The Takeout.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Record-breaking 2023 wildfires cost Quebec more than $8B
Researchers from the climate consulting firm Nada Conseils conducted a study that shed light on the economic impacts of the 2023 wildfires. They found the fires affected forestry and mining operations in the regions, caused financial losses for businesses and highlighted health-care costs linked to wildfire smoke.
.jpeg&w=3840&q=100)
Miami Herald
2 hours ago
- Miami Herald
Red panda known for ‘playful sass' dies, Utah zoo says. She was a guest favorite
An 8-year-old red panda known for her 'playful sass' and 'calm confidence' died after a severe health decline, Utah zookeepers said. Kiaria, a Chinese red panda, came to the Hogle Zoo in November as part of a breeding program by the Association of Zoos and Aquariums' Red Panda Species Survival Plan (SSP), according to an Aug. 18 news release by the Salt Lake City-based zoo. Kiaria had a history of gastrointestinal issues, which are common for red pandas, under human care, but in the recent months, she 'had been eating well, sleeping, and showing her playful personality,' the zoo said. On Aug. 14, her health began to rapidly decline, and after trying various treatments, the veterinary staff determined she would not recover, so she was humanely euthanized, zookeepers said. Gastrointestinal issues are the third-leading cause of death in Chinese red pandas living in North American zoos, SSP Red Panda co-vet advisor James Steeil said in the release. The 'confident' Kiaria, known as the 'boss of the cool room,' became a guest favorite after being debuted in March, the zoo said. She would spend time with William, a 2-year-old Chinese red panda, as part of the breeding program but preferred her own space as red pandas are 'naturally solitary,' the zoo said. Chinese red pandas have reddish coats and stripes on their tails with 'larger bodies and longer fur to help retain warmth,' zookeepers said. The species faces threats of habitat loss and poaching, causing a 40% decline in overall population of Chinese red pandasin the last 20 years, the zoo said. 'It was an immense privilege to have Kiaria in our care. She was a meaningful ambassador for her endangered species, helping to inspire greater understanding and appreciation for red pandas,' zookeepers said.
Yahoo
3 hours ago
- Yahoo
Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results
All financial results are reported in Canadian dollars unless otherwise stated. Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended February 28, 2025 ("Q2 2025"). Q2 2025 Performance Metrics For the quarter ended:Feb 28, 2025(Q2 2025) Feb 28, 2024(Q2 2024) % change Total Revenue $ 1,512,435$ 822,973 83.8%Cost of revenue1,007,691 365,446 175.7%Gross Profit (Loss) $ 504,744$ 457,527 10.3% Gross profit margin (loss)33.4% 55.6% -400 bpsOperating expenses and other items9,886,497 5,306,523 86.31%Loss and comprehensive loss($7,705,397 )($5,960,437 )n/a Balance Sheet and LiquidityNuminus ended the quarter with cash and cash equivalents of $705,631. Numinus' unaudited condensed consolidated interim financial statements for the three months ended February 28, 2025, and related management's discussion and analysis are available on Numinus' Investor Relations website at and under the Company's profile on SEDAR+ at These documents were prepared in accordance with IFRS. About NuminusNuminus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model — including psychedelic research and clinic care — is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society. Learn more at and follow us on LinkedIn, Facebook, Twitter, and Instagram. SOURCE: Numinus Wellness Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including, without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are "forward-looking statements". Forward-looking statements can be identified by the use of words such as "expects", "does not expect", "is expected", "believes", "intends", "anticipates", "does not anticipate", "believes" or variations of these words, expressions or statements, that certain actions, events or results "may", "could", "would", "might" or "will be" taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, ability of Numinus to maintain or increase earnings; ability of Numinus to achieve or maintain profitability; results of changes to operations from a financial or business perspective; the effect of cost containment measures on Numinus business and financial position; changes to cash burn rate, expenses, corporate programs or priorities, or unanticipated costs affecting cash runway or the pathway to positive cashflow or profitability, interest in, uptake of and the ability to commercialize the Numinus Training; availability of subjects and trainers for experiential opportunities in practitioners training, if approved; dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate the Company's facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, if any, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company's need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers; and other risk factors set forth in our annual information form dated July 25, 2025 and available on SEDAR+ at These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company's efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws. For more information:Investor ContactCraig MacPhailinvest@ To view the source version of this press release, please visit Sign in to access your portfolio
